Skip to content

Analysis of Characteristics in Chronic Fatigue Patients through Pupillary Response and Eye Movement

Analysis of Characteristics in Chronic Fatigue Patients through Pupillary Response and Eye Movement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009682
Enrollment
30
Registered
2024-08-06
Start date
2024-07-17
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dongguk University Bundang Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (Experimental Group) 1. Adult men and women aged 19 to 60 years 2. Fatigue VAS score = 40 3. Individuals capable of normal communication 4. Individuals who have signed the informed consent form (Control Group) 1. Adult men and women matching the experimental group in gender and age 2. Fatigue VAS score < 40 3. Individuals capable of normal communication 4. Individuals who have signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Individuals with uncontrolled hypertension, edema, diabetes, or thyroid dysfunction 2. Individuals with tuberculosis, multiple sclerosis, or uncontrolled asthma 3. Individuals with major depressive disorder, bipolar disorder, schizophrenia, dementia, delusional disorder, claustrophobia, or panic disorder 4. Individuals with moderate or severe insomnia (PSQI = 15) 5. Individuals with a body mass index (BMI) less than 18.5 kg/m² or greater than 30 kg/m² 6. Pregnant or breastfeeding individuals 7. Individuals with a history of alcohol or substance abuse within the past three months 8. Individuals who have regularly consumed health supplements or products that may affect fatigue (such as health supplements or fatigue recovery products) within the past month 9. Heavy smokers (25 cigarettes/day or more) 10. Individuals with central nervous system damage, including stroke 11. Users of electronic devices worn inside the body, such as pacemakers 12. Users of life-supporting electronic medical devices, such as artificial heart-lung machines 13. Users of wearable electronic medical devices, such as ECG machines 14. Individuals with skin diseases (including trauma, bleeding, fractures, malignant tumors, eyelid, skull, oral and genital areas, or infectious diseases) 15. Individuals with photosensitivity or severe visual impairment (excluding those whose vision is corrected by lenses or who can write without glasses) 16. Any other individuals deemed unsuitable for participation by the researcher

Design outcomes

Primary

MeasureTime frame
fatigue VAS;Fatigue Severity Scale (FSS);the modified Korean version of the Chalder Fatigue Scale(mKCFQ);pupillary response and eye movement

Secondary

MeasureTime frame
salivary cortisol;PSQI-K;vital sign;heart rate variety (HRV)

Countries

Korea, Republic of

Contacts

Public ContactSeo-Hyun Park

Dongguk University Bundang Oriental Hospital

barksh84@naver.com+82-31-710-3744

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026